https://charts.traderzeitung.de/phases/US6701002056
string(1496) "{"isin":"US6701002056","name":"Novo Nordisk AS","stock_id":137849568,"generated_at":"2026-10-05 22:20:00","days":[{"date":"2026-10-01","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":37.82,"close_at":"2026-10-01 15:29:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":37.405,"close_at":"2026-10-01 21:59:00","complete":true,"perf_pct":-1.0973},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":37.4,"close_at":"2026-10-02 01:18:00","complete":true,"perf_pct":-0.0134}]},{"date":"2026-10-02","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":37.58,"close_at":"2026-10-02 15:26:00","complete":true,"perf_pct":0.4813},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":37.295,"close_at":"2026-10-02 21:59:00","complete":true,"perf_pct":-0.7584},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":37.26,"close_at":"2026-10-02 23:55:00","complete":true,"perf_pct":-0.0938}]},{"date":"2026-10-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":36.94,"close_at":"2026-10-05 15:29:00","complete":true,"perf_pct":-0.8588},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":37.565,"close_at":"2026-10-05 21:59:00","complete":true,"perf_pct":1.6919},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":37.53,"close_at":"2026-10-05 22:10:00","complete":false,"perf_pct":-0.0932}]}]}"
Novo-Nordisk Aktie News & Nachrichten
Personalis (PSNL) im Rampenlicht: Strategische Partnerschaften und Merk-Beteiligung läuten neue Ära...
Aktie 1.) Rheinmetall - Defense-Spezialist profitiert von steigenden NATO-Etats - Berenberg hebt Kursziel...
US-Präsident Joe Biden hat eine Ausweitung der Kostenübernahme für Medikamente gegen Fettleibigkeit...
Analystenaufstufung: JPMorgan erhöht Kursziel um 10 % Innovative Medikamente : Neue Therapien...
